Mark Wedel

Experience

• 

  Alliance Pharmaceuticals

  Jan 1994 - Jan 2000

  Project Physician

  Led the Liquid Ventilation in ARDS trials through Phase 3 completion

• 

  Isis Pharmaceuticals, Inc.

  Jan 2001 - Jan 2007

  Sr. VP Clinical Development, CMO

  Lead the development of mipomersen from first-in-man through Phase II and up to licensing with Genzyme

• 

  Santaris Pharma A/S

  Aug 2009 - Aug 2010

  Chief Medical Officer, VP Clinical Development

  Successfully filed IND for the first microRNA antagonist in man and then successfully introduced the first microrRNA into human subjects with Hepatitis C

• 

  Ritter Pharmaceuticals, Inc.

  Feb 2012 - Apr 2012

  Chief Medical Officer

  Resigned.

• 

  AtheroNova, Inc.

  Dec 2012 - Feb 2015

  Senior VP Clinical Affairs & Chief Medical Officer

  Broad range of clinical development and operational skills, particularly in small startups and biotech requiring broad range of experiences and skills, primarily in those ventures taking on new challenges with unproven development pathways

• 

  Markadoc Clinical Consulting

  Jan 2015 - now

  Founder, President

  All aspects of clinical development, particularly in small start-up biotech requiring broad base of experiences and capabilities

• 

  Samaritan's Purse/WHO

  Mar 2017 - Apr 2017

  Volunteer Intensivist

  volunteer ICU physician working in portable 55 bed, 2 OR trauma hospital in war zone of Mosul, Iraq, treating victims of all identities, approximately 800 war trauma casualty surgeries per month